Raymond James & Associates Amarin Corp Plcuk Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Raymond James & Associates holds 33,784 shares of AMRN stock, worth $615,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,784
Previous 34,884 3.15%
Holding current value
$615,882
Previous $24,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$0.57 - $0.8 $627 - $880
-1,100 Reduced 3.15%
33,784 $21,000
Q2 2024

Jul 19, 2024
BUY
$0.63 - $1.07 $204 - $347
325 Added 0.94%
34,884 $24,000
Q1 2024

Apr 22, 2024
BUY
$0.82 - $1.35 $508 - $837
620 Added 1.83%
34,559 $30,000
Q4 2023

Jan 16, 2024
BUY
$0.66 - $0.91 $1,188 - $1,638
1,800 Added 5.6%
33,939 $29,000
Q3 2023

Oct 24, 2023
SELL
$0.85 - $1.43 $3,318 - $5,582
-3,904 Reduced 10.83%
32,139 $29,000
Q2 2023

Jul 25, 2023
BUY
$1.12 - $1.49 $614 - $818
549 Added 1.55%
36,043 $42,000
Q1 2023

Apr 14, 2023
BUY
$1.19 - $2.19 $2,380 - $4,380
2,000 Added 5.97%
35,494 $53,000
Q4 2022

Feb 08, 2023
SELL
$1.07 - $1.34 $5,152 - $6,452
-4,815 Reduced 12.57%
33,494 $40,000
Q2 2022

Aug 12, 2022
BUY
$1.13 - $3.69 $6,367 - $20,793
5,635 Added 17.25%
38,309 $57,000
Q1 2022

May 11, 2022
BUY
$2.85 - $3.73 $3,705 - $4,849
1,300 Added 4.14%
32,674 $107,000
Q4 2021

Feb 08, 2022
SELL
$3.24 - $5.18 $1,539 - $2,460
-475 Reduced 1.49%
31,374 $106,000
Q3 2021

Nov 02, 2021
SELL
$3.94 - $5.84 $8,632 - $12,795
-2,191 Reduced 6.44%
31,849 $162,000
Q2 2021

Aug 11, 2021
SELL
$4.26 - $6.5 $28,887 - $44,076
-6,781 Reduced 16.61%
34,040 $149,000
Q1 2021

May 14, 2021
BUY
$5.03 - $8.8 $53,821 - $94,160
10,700 Added 35.52%
40,821 $253,000
Q4 2020

Feb 12, 2021
SELL
$4.04 - $5.31 $1.5 Million - $1.97 Million
-370,059 Reduced 92.47%
30,121 $147,000
Q3 2020

Nov 04, 2020
BUY
$3.64 - $7.76 $43,785 - $93,345
12,029 Added 3.1%
400,180 $1.69 Million
Q2 2020

Jul 28, 2020
BUY
$4.78 - $8.26 $173,776 - $300,292
36,355 Added 10.33%
388,151 $2.69 Million
Q1 2020

Apr 21, 2020
SELL
$4.0 - $21.53 $163,464 - $879,844
-40,866 Reduced 10.41%
351,796 $1.41 Million
Q4 2019

Feb 12, 2020
BUY
$13.94 - $24.12 $780,012 - $1.35 Million
55,955 Added 16.62%
392,662 $8.42 Million
Q3 2019

Nov 07, 2019
BUY
$13.89 - $23.16 $2.05 Million - $3.41 Million
147,307 Added 77.78%
336,707 $5.1 Million
Q2 2019

Aug 06, 2019
BUY
$16.27 - $20.51 $297,204 - $374,656
18,267 Added 10.67%
189,400 $3.67 Million
Q1 2019

May 06, 2019
BUY
$12.61 - $22.33 $616,982 - $1.09 Million
48,928 Added 40.04%
171,133 $3.55 Million
Q4 2018

Feb 11, 2019
BUY
$12.41 - $22.98 $237,663 - $440,089
19,151 Added 18.58%
122,205 $1.66 Million
Q3 2018

Nov 14, 2018
BUY
$2.45 - $16.27 $37,654 - $250,053
15,369 Added 17.53%
103,054 $1.68 Million
Q2 2018

Aug 14, 2018
BUY
$2.68 - $3.48 $10,076 - $13,084
3,760 Added 4.48%
87,685 $271,000
Q1 2018

May 14, 2018
BUY
$2.99 - $4.44 $80,999 - $120,279
27,090 Added 47.66%
83,925 $253,000
Q4 2017

Feb 14, 2018
SELL
$3.06 - $4.09 $75,138 - $100,429
-24,555 Reduced 30.17%
56,835 $228,000
Q3 2017

Nov 13, 2017
SELL
$3.03 - $3.72 $12,120 - $14,880
-4,000 Reduced 4.68%
81,390 $285,000
Q2 2017

Aug 14, 2017
BUY
N/A
85,390
85,390 $344,000

Others Institutions Holding AMRN

# of Institutions
28
Shares Held
3.61M
Call Options Held
0
Put Options Held
0
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $7.35B
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email